CCL2 and gastric cancer: Studies have demonstrated that phosphorylation of Akt and mTOR was increased in DDP-resistant gastric cancer cells and inhibition of PI3K/Akt pathway significantly attenuated CCL2-mediated DDP-resistance in gastric cancer (Xu et al., 2018).